发表于 2023-3-11 09:17:17
来源:http://www.bbs22.cn
The Expert Panel emphasized that the decision about extended AI therapy required discussion with the individual patient and shared decision making based on an understanding of the individual patient s risk factors for recurrence, treatment experience, and tolerability during the first 5 years of therapy as well as the likely benefits of prevention of second, contralateral, or ipsilateral breast cancers and the lack of known survival advantage for extended AI monotherapy <a href=https://accutane.buzz>comprar accutane in usa</a> |
|